Silver Spring Woman Becomes First Adult Sickle Cell Disease Patient in Maryland to Receive FDA-Approved Gene Therapy
Doctors at the University of Maryland Medical Center Treat 41-Year-Old Patient with Her Own Genetically Modified Stem Cells in a Promising Chance for a Cure
Greenebaum Family Donates $5.5 Million to Advance Cancer Research and Patient Care
Funding Designated for the University of Maryland Greenebaum Comprehensive Cancer Center Extends Family’s 30-Year Legacy of Philanthropy, Commitment to Health Care and Community